China will allow the use of data from overseas clinical trials for approvals of new drugs, in a move likely to enable multinationals to bring products to the world’s second-largest pharmaceutical market more quickly.
中國(guó)將在審批新藥時(shí)接受境外臨床試驗(yàn)數(shù)據(jù)，此舉可能使得跨國(guó)企業(yè)更迅速地把藥品引入世界第二大醫(yī)藥市場(chǎng)。
您已閱讀7%（265字），剩余93%（3438字）包含更多重要信息，訂閱以繼續(xù)探索完整內(nèi)容，并享受更多專屬服務(wù)。